Analyst Ratings for Home Properties (HME)
HME Rating Summary
HME Price Target Summary
- Highest: $72.00 (Barclays)
- Lowest: $57.00 (UBS)
- Average: $62.79
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$62.79 (-5.6%)
Avg. $ Target:
$62.79 (-5.6%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/6/2012 | RBC Capital | Downgrade | Underperform (Sector Perform) |
62.00 (64.00) |
61.93 | 66.52 | 7.41% | Details |
| 11/2/2012 | Miller Tabak | Upgrade | Strong Buy (Neutral) |
N/A (N/A) |
61.76 | 66.52 | 7.71% | Details |
| 2/1/2012 | Keefe, Bruyette & Woods | Upgrade | Market Perform (N/A) |
62.00 (N/A) |
59.58 | 66.52 | 11.65% | Details |
| 2/1/2012 | Cantor Fitzgerald | New Coverage | Sell (N/A) |
59.50 (N/A) |
59.58 | 66.52 | 11.65% | Details |
| 1/23/2012 | Compass Point | New Coverage | Buy (N/A) |
N/A (N/A) |
55.43 | 66.52 | 20.01% | Details |
| 1/4/2012 | Morgan Keegan | Downgrade | Market Perform (N/A) |
N/A (N/A) |
57.31 | 66.52 | 16.07% | Details |
| 11/7/2011 | ISI Group | Upgrade | Buy (N/A) |
62.00 (N/A) |
57.23 | 66.52 | 16.23% | Details |
| 10/31/2011 | UBS » Updated 2/14/2012 |
Downgrade | Sell (N/A) |
57.00 (N/A) |
59.68 | 66.52 | 11.46% | Details |
| 8/8/2011 | Baird | Upgrade | Outperform (N/A) |
65.00 (N/A) |
57.34 | 66.52 | 16.01% | Details |
| 8/8/2011 | BofA/Merrill Lynch | Upgrade | Buy (N/A) |
N/A (N/A) |
57.34 | 66.52 | 16.01% | Details |
| 5/11/2011 | Wunderlich Securities | New Coverage | Buy (N/A) |
N/A (N/A) |
62.09 | 66.52 | 7.13% | Details |
| 3/1/2011 | Stifel Nicolaus | Downgrade | Hold (N/A) |
N/A (N/A) |
58.92 | 66.52 | 12.9% | Details |
| 1/14/2011 | KeyBanc | Downgrade | Hold (N/A) |
N/A (N/A) |
53.20 | 66.52 | 25.04% | Details |
| 9/20/2010 | FBR Capital » Updated 7/1/2011 |
Upgrade | Outperform (N/A) |
N/A (N/A) |
51.41 | 66.52 | 29.39% | Details |
| 8/27/2010 | Janney Montgomery Scott | New Coverage | Buy (N/A) |
N/A (N/A) |
49.77 | 66.52 | 33.65% | Details |
